Alan LeFevre, a director at
Herbalife Nutrition (HLF), recently bought 3,000 additional shares. The buy increased his stake by over 19 percent, and came to a total cost of just under $145,0000.
This follows up on two other insider buys earlier in the month, when the company CFO bought 425 shares at a cost of over $20,000, and the company CEO bought 5,200 shares at a price of about $250,000.
Prior to that, insiders have largely been sellers over the past three years. Overall, company insiders own about 11.5 percent of company shares.
The health supplement company has seen share rise just over 1 percent in the past year, effectively flatlining against a sizeable gain for the S&P 500. But shares trade at 10 times forward earnings, and the company has double-digit revenue and earnings growth.
Action to take: Shares look undervalued by most conventional measures, especially with reasonable growth rates relative to that value. Investors may like shares, although the stock doesn’t pay a dividend.
For traders, the recent bout of insider buying may indicate an attempt to move higher in line with the current uptrend in shares. The January $50 calls, last going with a bid/ask spread of about $3.10, could lead to mid-to-high double-digit growth in the next few months.
Disclosure: The author of this article has no position in the company mentioned here, but may make a trade after the next 72 hours. The author receives no compensation from any of the companies mentioned in this article.
